Abstract

BackgroundReliable exon recognition is key to the splicing of pre-mRNAs into mature mRNAs. TDP-43 is an RNA-binding protein whose nuclear loss and cytoplasmic aggregation are a hallmark pathology in amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). TDP-43 depletion causes the aberrant inclusion of cryptic exons into a range of transcripts, but their extent, relevance to disease pathogenesis and whether they are caused by other RNA-binding proteins implicated in ALS/FTD are unknown.MethodsWe developed an analysis pipeline to discover and quantify cryptic exon inclusion and applied it to publicly available human and murine RNA-sequencing data.ResultsWe detected widespread cryptic splicing in TDP-43 depletion datasets but almost none in another ALS/FTD-linked protein FUS. Sequence motif and iCLIP analysis of cryptic exons demonstrated that they are bound by TDP-43. Unlike the cryptic exons seen in hnRNP C depletion, those repressed by TDP-43 cannot be linked to transposable elements. Cryptic exons are poorly conserved and inclusion overwhelmingly leads to nonsense-mediated decay of the host transcript, with reduced transcript levels observed in differential expression analysis. RNA-protein interaction data on 73 different RNA-binding proteins showed that, in addition to TDP-43, 7 specifically bind TDP-43 linked cryptic exons. This suggests that TDP-43 competes with other splicing factors for binding to cryptic exons and can repress cryptic exon inclusion.ConclusionsOur quantitative analysis pipeline confirms the presence of cryptic exons during the depletion of TDP-43 but not FUS providing new insight into to RNA-processing dysfunction as a cause or consequence in ALS/FTD.

Highlights

  • Reliable exon recognition is key to the splicing of pre-mRNAs into mature mRNAs

  • Boundaries that demarcate exons from introns are first recognised by the binding of the U1 small nuclear RNA to the 5′ splice site at the beginning of the intron and the U2 snRNA binding to the polypyrimidine tract and 3′ splice site at the end of the intron

  • Depletion of TDP-43 but not FUS results in cryptic exons We compared the involvement of two amyotrophic lateral sclerosis (ALS)-linked RNA-binding proteins in cryptic splicing: TDP-43 and FUS

Read more

Summary

Introduction

Reliable exon recognition is key to the splicing of pre-mRNAs into mature mRNAs. TDP-43 is an RNAbinding protein whose nuclear loss and cytoplasmic aggregation are a hallmark pathology in amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). Due to the long length and reduced evolutionary conservation of intronic sequences, pairs of 3′ and 5′ splice sites can emerge randomly to create potentially new exons. These cryptic exons ( known as pseudoexons) arise due to mutations that create new splice sites or remove the existing binding sites for splicing repressors. These type of mutations have been implicated in a number of genetic diseases [2,3,4,5]. The former can occur by the nonsensemediated decay (NMD) pathway, which occurs when a transcript has a premature termination codon introduced either directly by the cryptic exon or by a subsequent shift of reading frame [6, 7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call